Nationwide Fund Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Nationwide Fund Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,620	Closed	-$84K	–	3325
2016 Q1	$84K	Hold	15,620	–	–	﹤0.01%	2876
2015 Q4	$185K	Sell	15,620 -100	-0.6%	-$1.14K	﹤0.01%	2599
2015 Q3	$129K	Sell	15,720 -28,600	-65%	-$330K	﹤0.01%	2801
2015 Q2	$618K	Buy	44,320 +28,450	+179%	+$522K	﹤0.01%	2128
2015 Q1	$381K	Sell	15,870 -4,011	-20%	-$90.2K	﹤0.01%	2374
2014 Q4	$327K	Sell	19,881 -600	-3%	-$6.92K	﹤0.01%	2415
2014 Q3	$261K	Hold	20,481	–	–	﹤0.01%	2570
2014 Q2	$462K	Buy	20,481 +1,503	+8%	+$27.3K	﹤0.01%	2301
2014 Q1	$536K	Buy	+18,978	New	+$705K	﹤0.01%	2030

Other funds holding DRNA

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Nationwide Fund Advisors's DRNA Position: Q2 2016 in Review

Nationwide Fund Advisors sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2016, closing a stake of 15,620 shares — an estimated $84K sold.

Nationwide Fund Advisors first reported a position in DRNA in Q1 2014 and held it in 9 quarters. The position peaked at $618K in Q2 2015. 53 funds tracked by Wall St. Rank hold DRNA as of Q2 2016.

Nationwide Fund Advisors reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 15,620 Dicerna Pharmaceuticals, Inc. shares in Q2 2016, an estimated $84K.
Nationwide Fund Advisors first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 9 quarters.
Nationwide Fund Advisors's Dicerna Pharmaceuticals, Inc. position peaked at $618K in Q2 2015.
53 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2016.

Based on Nationwide Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.